The Chan Zuckerberg Initiative (CZI) is inviting applications from collaborative teams bringing together patient-led rare disease organisations and research teams for 4-year research projects aimed at advancing understanding of the fundamental science of rare diseases across two requests for applications (RFAs):
- The Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease RFA aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases in order to clarify cellular mechanisms of disease, improve understanding of disease heterogeneity, identify biomarkers, and improve diagnosis. Patient organizations are expected to be active collaborators on this research opportunity and full partners in the development of the grant application.
- The Patient-Partnered Collaborations for Rare Neurodegenerative Disease RFA aims to advance the understanding of the pathophysiology and mechanistic underpinnings of rare neurodegenerative and neurological disorders.
For more information about these RFAs, an informational webinar is being organised on February 16th from 18.00 – 19.00 CET.
To register for the webinar: https://app.smartsheet.com/b/form/c3778f11ace64be3a2e0cec66b11ea4f
The deadline for submitting applications is May 24th.
For more information and to complete the RFAs: https://apply.chanzuckerberg.com/